Evidence map›Paper›PMID 40439389›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Association of Selective VDR Gene Polymorphisms with Diffuse Large B-Cell Lymphoma (DLBCL) in a South Indian Population.

Annuja Anandaradje, Shravan Venkatraman, Luxitaa Goenka, Prasanth Ganesn, Shyam Kumar Tripathi, Jayanthi Mathaiyan, Sandhiya Selvarajan

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. VDR Gene Polymorphisms and Diffuse Large B-Cell Lymphoma: Correspondence.Asian Pacific journal of cancer prevention : APJCP · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Annuja AnandaradjeDepartment of Clinical Pharmacology, Institute Block, JIPMER, Dhanvantri Nagar, Gorimedu, Pondicherry, India.ORCID 0000-0002-1020-1282
Shravan VenkatramanDepartment of Clinical Pharmacology, Institute Block, JIPMER, Dhanvantri Nagar, Gorimedu, Pondicherry, India.
Luxitaa GoenkaDepartment of Medical Oncology, JIPMER, Dhanvantri Nagar, Gorimedu, Pondicherry, India.
Prasanth GanesnDepartment of Medical Oncology, JIPMER, Dhanvantri Nagar, Gorimedu, Pondicherry, India.
Shyam Kumar TripathiDepartment of Pharmacology, JIPMER, Dhanvantri Nagar, Gorimedu, Pondicherry, India.
Jayanthi MathaiyanDepartment of Pharmacology, JIPMER, Dhanvantri Nagar, Gorimedu, Pondicherry, India.
Sandhiya SelvarajanDepartment of Clinical Pharmacology, Institute Block, JIPMER, Dhanvantri Nagar, Gorimedu, Pondicherry, India.ORCID 0000-0002-7948-7821

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of Diffuse Large B-Cell Lymphoma (DLBCL) in India ranges from 34% to 60%. The prognosis for DLBCL can vary widely depending on various factors, including vitamin D deficiency. Research suggests that low vitamin D levels may be linked to poor overall survival (OS) and progression-free survival (PFS) in DLBCL patients. Additionally, polymorphisms in the vitamin D receptor (VDR) gene, specifically the BsmI and TaqI alleles, have been significantly associated with disease prognosis. However, the association of VDR polymorphisms and vitamin D deficiency with DLBCL is yet to be explored. Therefore, this study aims to evaluate the association of VDR gene polymorphisms (BsmI, TaqI, FokI, ApaI) in DLBCL patients.

methodsIn this cross-sectional study, 50 treatment-naive DLBCL patients from southern part of India were included. 100 samples of unrelated apparently healthy controls were used as comparator. Demographic characteristics of DLBCL patients were recorded and SNPs in VDR (real time polymerase chain reaction) were assessed. All analyses were performed using SPSS (V26). P<0.05 was considered statistically significant.

resultsThe frequencies of mutant genotypes [TT- BsmI, AG- TaqI and AG- FokI] were significantly associated with a reduced risk of DLBCL, decreasing the risk DLBCL by 71% (OR=0.29, 95% CI= 0.105 to 0.807), 72% (OR=0.28, 95% CI= 0.133 to 0.608) and 70% (OR=0.3, 95% CI= 0.07 to 1.225). Additionally, comparison with other Indian studies and ethnic groups revealed significant distinctions in VDR genotypes. Further, the haplotype analysis of SNPs in the VDR gene revealed significant association of C-A-G-T haplotype (rs731236-rs7975232-rs1544410-rs2228570) with the disease phenotype.

conclusionThe study shows significant association of BsmI, TaqI, and FokI VDR SNPs with DLBCL.

Indexed as

Biomarkers, TumorGenetic Predisposition to DiseaseLymphoma, Large B-Cell, DiffusePolymorphism, Single NucleotideReceptors, CalcitriolAdultAgedCase-Control StudiesCross-Sectional StudiesFemaleFollow-Up StudiesGenotypeHumansIndiaMaleMiddle AgedBiomarkers, TumorReceptors, CalcitriolVDR protein, humanHaplotypeKey words: DLBCLSNPVDR polymorphismVitamin D

Identifiers

PMID40439389
PMCPMC12290187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.